|Day Low/High||2.91 / 3.07|
|52 Wk Low/High||1.35 / 5.64|
Few parts of the market have more volatility than the small caps in this sector.
The volatility trade that propped up markets is no longer available.
The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.
The Burlington, Mass.-based firm announced a proposed public offering of 4 million shares. It plans to use part of the net proceeds to fund manufacturing and commercialization of osteoarthritis knee pain treatment Zilretta.